Large-scale testing (Phase 3)Study completedNCT00481325
What this trial is testing
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Who this might be right for
Generalized Anxiety Disorder
Bristol-Myers Squibb 260